Anti-CCPG1 Antibody, clone 1F15 ZooMAb^® Rabbit Monoclonal

200

rabbit

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

1F15, monoclonal
recombinant monoclonal

ZooMAb^® learn more

lyophilized

calculated mol wt 87.34 kDa
observed mol wt ~34 kDa (recombinant fragment)
observed mol wt ~90 kDa

human

antibody small pack of 25 μL

Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

recombinant expression
Learn more about Antibody Enhanced Validation

affinity binding assay: suitable
immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable

IgG

Aligned

ambient

2-8℃

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.

Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.

Learn more about ZooMAb here.

Clone 1F15 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects human Cell cycle progression protein 1 (CCPG1). It targets an epitope within the lumenal domain in the C-terminal half.

His-tagged recombinant fragment corresponding to 250 amino acids from the C-terminal, lumenal domain of human Cell cycle progression protein 1 (CCPG1).

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected CCPG1 in A549 cell lysate.

Affinity Binding Assay: A representative lot of this antibody bound recombinant CCPG1 with a KD of 3.9 x 10-7 in an affinity binding assay.

Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected CCPG1 in SK-MEl-28 cells.

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected CCPG1 in human small intestine tissue sections.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-CCPG1, clone 1F15 ZooMAb, Cat. No. ZRB1582, is a recombinant Rabbit monoclonal antibody that specifically targets CCPG1 and is tested for use in Affinity Binding Assay, Immunocytochemistry, Immunohistochemistry, and Western Blotting.

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Cell cycle progression protein 1 (UniProt: Q9ULG6; also known as Cell cycle progression restoration protein 8, CCPG1) is encoded by the CCPG1 (also known as CCP8, CPR8, KIAA1254) gene (Gene ID: 9236) in human. CCPG1 is a single-pass type II membrane protein that acts as an assembly platform for Rho protein signaling complexes. It is reported to mediate recruitment of endogenous Src kinase into Dbs-containing complexes and interacts with the Rho family member Cdc42. It limits guanine nucleotide exchange activity of MCF2L toward RHOA, which results in an inhibition of both its transcriptional activation ability and its transforming activity. However, it does not inhibit activity of MCF2L toward CDC42, or activity of MCF2 toward either RHOA or CDC42. CCPG1 also serves as an ER stress-inducible endoplasmic reticulum (ER)-phagy cargo receptor in mammals. It is shown to bind directly to ATG8 and FIP200 via distinct peptide motifs. It is reported to offer protection against ER luminal protein aggregation and consequent unfolded protein response hyperactivation and tissue injury of the exocrine pancreas. CCPG1 contains a cytoplasmic domain (aa 1-217), a transmembrane domain (aa 218-238), and a luminal domain (aa 239-757). This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Smith, MD., et al. (2018). Dev. Cell. 44(2); 217-232; Kostenko EV., et al. (2006). Mol. Cell. Biol. 26(23); 8964-8975).

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

11 - Combustible Solids

WGK 1